343 related articles for article (PubMed ID: 15175625)
41. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
[TBL] [Abstract][Full Text] [Related]
42. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation.
Hammadi A; Billard C; Faussat AM; Kolb JP
Nitric Oxide; 2008 Sep; 19(2):138-45. PubMed ID: 18474259
[TBL] [Abstract][Full Text] [Related]
43. Different proliferative and survival capacity of CLL-cells in a newly established in vitro model for pseudofollicles.
Plander M; Seegers S; Ugocsai P; Diermeier-Daucher S; Iványi J; Schmitz G; Hofstädter F; Schwarz S; Orsó E; Knüchel R; Brockhoff G
Leukemia; 2009 Nov; 23(11):2118-28. PubMed ID: 19657365
[TBL] [Abstract][Full Text] [Related]
44. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.
Ringshausen I; Dechow T; Schneller F; Weick K; Oelsner M; Peschel C; Decker T
Leukemia; 2004 Dec; 18(12):1964-70. PubMed ID: 15483673
[TBL] [Abstract][Full Text] [Related]
45. Chronic low-dose radiation inhibits the cells death by cytotoxic high-dose radiation increasing the level of AKT and acinus proteins via NF-κB activation.
Park HS; Seong KM; Kim JY; Kim CS; Yang KH; Jin YW; Nam SY
Int J Radiat Biol; 2013 May; 89(5):371-7. PubMed ID: 23205493
[TBL] [Abstract][Full Text] [Related]
46. BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.
Asslaber D; Wacht N; Leisch M; Qi Y; Maeding N; Hufnagl C; Jansko B; Zaborsky N; Villunger A; Hartmann TN; Greil R; Egle A
Clin Cancer Res; 2019 Mar; 25(6):1901-1912. PubMed ID: 30487125
[TBL] [Abstract][Full Text] [Related]
47. AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1.
Schrader A; Popal W; Lilienthal N; Crispatzu G; Mayer P; Jones D; Hallek M; Herling M
Curr Cancer Drug Targets; 2014; 14(8):700-12. PubMed ID: 25348018
[TBL] [Abstract][Full Text] [Related]
48. Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place.
Herreros B; Rodríguez-Pinilla SM; Pajares R; Martínez-Gónzalez MA; Ramos R; Munoz I; Montes-Moreno S; Lozano M; Sánchez-Verde L; Roncador G; Sánchez-Beato M; de Otazu RD; Pérez-Guillermo M; Mestre MJ; Bellas C; Piris MA
Leukemia; 2010 Apr; 24(4):872-6. PubMed ID: 20072150
[No Abstract] [Full Text] [Related]
49. Loss of cooperativity of secreted CD40L and increased dose-response to IL4 on CLL cell viability correlates with enhanced activation of NF-kB and STAT6.
Bhattacharya N; Reichenzeller M; Caudron-Herger M; Haebe S; Brady N; Diener S; Nothing M; Döhner H; Stilgenbauer S; Rippe K; Mertens D
Int J Cancer; 2015 Jan; 136(1):65-73. PubMed ID: 24828787
[TBL] [Abstract][Full Text] [Related]
50. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
Ferretti E; Bertolotto M; Deaglio S; Tripodo C; Ribatti D; Audrito V; Blengio F; Matis S; Zupo S; Rossi D; Ottonello L; Gaidano G; Malavasi F; Pistoia V; Corcione A
Leukemia; 2011 Aug; 25(8):1268-77. PubMed ID: 21546901
[TBL] [Abstract][Full Text] [Related]
51. The proteasome inhibitor carfilzomib functions independently of p53 to induce cytotoxicity and an atypical NF-κB response in chronic lymphocytic leukemia cells.
Gupta SV; Hertlein E; Lu Y; Sass EJ; Lapalombella R; Chen TL; Davis ME; Woyach JA; Lehman A; Jarjoura D; Byrd JC; Lucas DM
Clin Cancer Res; 2013 May; 19(9):2406-19. PubMed ID: 23515408
[TBL] [Abstract][Full Text] [Related]
52. The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies.
Daneshmanesh AH; Hojjat-Farsangi M; Moshfegh A; Khan AS; Mikaelsson E; Österborg A; Mellstedt H
Br J Haematol; 2015 May; 169(3):455-8. PubMed ID: 25407287
[No Abstract] [Full Text] [Related]
53. Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells.
Wickremasinghe RG; Ganeshaguru K; Jones DT; Lindsay C; Spanswick VJ; Hartley JA; Wadhwa M; Thorpe R; Hoffbrand AV; Prentice HG; Mehta AB
Br J Haematol; 2001 Sep; 114(3):608-15. PubMed ID: 11552986
[TBL] [Abstract][Full Text] [Related]
54. BCL-3 expression promotes colorectal tumorigenesis through activation of AKT signalling.
Urban BC; Collard TJ; Eagle CJ; Southern SL; Greenhough A; Hamdollah-Zadeh M; Ghosh A; Poulsom R; Paraskeva C; Silver A; Williams AC
Gut; 2016 Jul; 65(7):1151-64. PubMed ID: 26033966
[TBL] [Abstract][Full Text] [Related]
55. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
56. Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells.
Avellino R; Romano S; Parasole R; Bisogni R; Lamberti A; Poggi V; Venuta S; Romano MF
Blood; 2005 Aug; 106(4):1400-6. PubMed ID: 15878982
[TBL] [Abstract][Full Text] [Related]
57. Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.
Hu X; Haney N; Kropp D; Kabore AF; Johnston JB; Gibson SB
J Biol Chem; 2005 Mar; 280(10):9498-508. PubMed ID: 15618220
[TBL] [Abstract][Full Text] [Related]
58. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.
Ghosh AK; Kay NE; Secreto CR; Shanafelt TD
Clin Cancer Res; 2009 Feb; 15(4):1250-8. PubMed ID: 19228728
[TBL] [Abstract][Full Text] [Related]
59. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.
Pedersen IM; Kitada S; Leoni LM; Zapata JM; Karras JG; Tsukada N; Kipps TJ; Choi YS; Bennett F; Reed JC
Blood; 2002 Sep; 100(5):1795-801. PubMed ID: 12176902
[TBL] [Abstract][Full Text] [Related]
60. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression.
Dhawan P; Singh AB; Ellis DL; Richmond A
Cancer Res; 2002 Dec; 62(24):7335-42. PubMed ID: 12499277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
